Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02130700
What this trial is testing

Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer

Who this might be right for
Prostate Cancer
Innocrin Pharmaceutical 17
Early research (Phase 1)UnknownNCT03403595
What this trial is testing

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 30
Early research (Phase 1)Ended earlyNCT02963051
What this trial is testing

A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Daniel George, MD 9
Testing effectiveness (Phase 2)Ended earlyNCT02095717
What this trial is testing

Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)

Who this might be right for
Prostate Cancer Metastatic Castration Resistant
Centre Jean Perrin 50
Not applicableLooking for participantsNCT06514521
What this trial is testing

Post Marketing Study on Pluvicto in Korea

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 278
Testing effectiveness (Phase 2)Looking for participantsNCT06616155
What this trial is testing

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
University of Michigan Rogel Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT04846478
What this trial is testing

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT01748500
What this trial is testing

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 21
Early research (Phase 1)Study completedNCT02532114
What this trial is testing

Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
University of Washington 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Testing effectiveness (Phase 2)Ended earlyNCT02146833
What this trial is testing

SHIP (Selinexor in Hormone Insensitive Prostate Cancer)

Who this might be right for
Prostate Cancer
Karyopharm Therapeutics Inc 20
Early research (Phase 1)UnknownNCT05973149
What this trial is testing

Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT02218606
What this trial is testing

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07667400
What this trial is testing

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaParanasal Sinus Neoplasms+9 more
National Cancer Institute (NCI) 120
Not applicableLooking for participantsNCT07096999
What this trial is testing

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate Carcinoma
University of Michigan Rogel Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT01615120
What this trial is testing

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
GTx 77
Not applicableUnknownNCT02208583
What this trial is testing

Molecular Phenotype Changes and Personalized Treatment for CRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital 150
Early research (Phase 1)Looking for participantsNCT07570979
What this trial is testing

Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 208
Testing effectiveness (Phase 2)Study completedNCT01199146
What this trial is testing

Abiraterone Post Ketoconazole for Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 42
Next Page